Brace will be attending the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on September 14-16 August 5, 2020 by Brace Pharma Capital
Brace will be attending the Wedbush Pacgrow Healthcare Conference in New York City from August 11-12, 2020 August 5, 2020 by Brace Pharma Capital
Brace will be attending the Wedbush Pacgrow Healthcare Conference in New York City from August 13-14, 2019 July 10, 2019 by Brace Pharma Capital
Brace will be attending the Jefferies 2019 Global Healthcare Conference in New York City from June 4-7, 2019 May 7, 2019 by Brace Pharma Capital
Lilly and Avidity Biosciences Announce Licensing and Research Collaboration April 22, 2019 by Brace Pharma Capital
Brace will be attending the World Orphan Drug Congress USA in Oxon Hill, MD from April 11-12, 2019 April 1, 2019 by Brace Pharma Capital
Brace will be attending the Cowen & Company 39th Annual Healthcare Conference in Boston, MA from March 11-March 13, 2019 March 5, 2019 by Brace Pharma Capital
Brace will be attending the Leerink Partners Annual Global Healthcare Conference in New York from February 27-March 1, 2019 February 14, 2019 by Brace Pharma Capital
Brace will be attending the JP Morgan Healthcare Conference in San Fransisco from January 7-10, 2019 December 6, 2018 by Brace Pharma Capital
Brace will be attending the RESI New York Conference on November 5 in New York City October 22, 2018 by Brace Pharma Capital
Brace will be attending BIO-Europe in Denmark November 5-7, 2018 October 22, 2018 by Brace Pharma Capital
Brace will be attending the Cowen & Co Therapeutics Conference on October 9th and 10th in New York City September 17, 2018 by Brace Pharma Capital
Brace will be attending the BIO Investor Forum on October 17th and 18th in San Francisco, CA September 17, 2018 by Brace Pharma Capital
Brace will be attending the BioPharm America Conference on September 5-6 in Boston, MA August 23, 2018 by Brace Pharma Capital
Brace will be attending the RESI Boston Conference on September 6 in Boston, MA August 23, 2018 by Brace Pharma Capital
UNUM THERAPEUTICS ANNOUNCES ACTIVE INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR ANTIBODY-COUPLED T CELL RECEPTOR (ACTR) PLATFORM IN COMBINATION WITH TRASTUZUMAB IN PATIENTS WITH HER2+ ADVANCED CANCERS August 14, 2018 by Brace Pharma Capital
Brace will be attending the Wedbush PacGrow Healthcare Conference on August 15-16 in New York City July 25, 2018 by Brace Pharma Capital
Brace will be attending The Oppenheimer Newport Summit for Revolutionary Biotechnology in Newport, RI on August 12-13, 2018 July 25, 2018 by Brace Pharma Capital
Unum Therapeutics to Present Pre-Clinical Data on its Antibody-Coupled T Cell Receptor (ACTR) Platform at the American Society of Hematology (ASH) Summit on Emerging Immunotherapies for Hematological Diseases July 13, 2018 by Brace Pharma Capital
Miragen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201 July 12, 2018 by Brace Pharma Capital
Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs June 27, 2018 by Brace Pharma Capital
Brace will be attending the Jefferies 2018 Global Healthcare Conference from June 5-8, 2018 in New York May 7, 2018 by Brace Pharma Capital
Brace will be attending the American Society of Gene & Cell Therapy Meeting in Chicago on May 15-18, 2018 May 7, 2018 by Brace Pharma Capital
Brace will be attending the World Orphan Drug Congress in Washington DC on Apr 26-27th, 2018 March 30, 2018 by Brace Pharma Capital
Brace will be attending the BioHealth Capital Region Forum in Gaithersburg, MD on Mar 23-24, 2018 March 28, 2018 by Brace Pharma Capital
Brace will be attending the Cowen Health Care Conference in Boston from Mar 12-14, 2018 February 26, 2018 by Brace Pharma Capital
Brace will be attending the Leerink Partners Global Healthcare Conference in New York on Feb 14-15, 2018 January 29, 2018 by Brace Pharma Capital
